Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 7Cholangiocarcinoma 2Diabetes Mellitus 1Cirrhosis, Familial, with Pulmonary Hypertension 1Carcinoma 1

Interventions

Fluorouracil 3lenvatinib 2Oxaliplatin 2Leucovorin 2Drug Therapy 2gemcitabine-oxaliplatin regimen 1durvalumab 1donafenib 1apatinib 1Surgical Procedures, Operative 1Irinotecan 1Folfox protocol 1Floxuridine 1Dexamethasone 1Cryosurgery 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cirrhosis, Familial, with Pulmonary Hypertension × donafenib × 1 year × Clear all
NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Sun Yat-sen University

Phase 2 Not yet recruiting
36 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡